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and using the same patient anatomy and fractionation 
schedule virtual plans for intensity modulated radiotherapy 
(IMRT) were made. The PTV in IMRT plans was created by 5 
mm volumetric extension around the PTV used in BT plans. 
PTVeval was formed from PTV with geometrical limitation to 
the skin. Detailed dose-volume histogram analysis was carried 
out for the PTVs, breasts, lungs, skin, ribs and heart. Means, 
standard deviations were calculated and the corresponding 
parameters were statistically compared. Wilcoxon matched 
pairs analysis was performed for test of significance. 
 
Results: The target coverage represented by V90 was better 
for IMRT (100% vs. 97%, p<0.05), but the D90 was higher for 
BT (103% vs. 100%, p<0.05). The conformity numbers were 
0.73 for BT and 0.84 for IMRT (p<0.05). The V100, V90 and 
V50 for non-target breast were 1.7% vs. 0.2% (p<0.05), 2.8% 
vs. 4.3% (p<0.05) and 11.5% vs. 23.9% (p<0.05) for BT and 
IMRT plans, respectively. For ipsilateral lung the V5 was not 
significantly different in the two groups, but the V10 was 
lower for BT (11.7% vs. 20.5%, p<0.05). For contralateral 
breast and lung no significant differences in D0.1ccm were 
observed. For patients with left sided lesion the dose to 
heart was less with IMRT for D0.1ccm (15.3% vs. 22.7%, 
p<0.05). The most exposed skin volume (0.1 ccm) received 
significantly less dose with BT (64.4% vs. 92.4%). The same is 
true for ribs with values of 51.3% vs. 71.2%. With BT the ribs 
never received the prescribed dose, while with IMRT the 
D0.1ccm exceeded the prescribed dose in five cases. 
 
Conclusion: With both BT and IMRT techniques acceptable 
target coverage can be obtained, but the conformity of dose 
distributions is better with IMRT. The dose to organs at risk is 
less with BT compared to IMRT, except for the heart. 
Generally, the BT and IMRT can be alternative techniques for 
partial breast irradiation, but in individual cases the 
recommended technique depends on the tumour location. 
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Purpose or Objective: To report the initial outcomes of 
patients treated with the MammoSite brachytherapy device 
(MSBT) as a boost followed by external whole breast 
irradiation (WBI). 
 
Material and Methods: From June 2011 to March 2014, 107 
patients (typically pT1-2, pN0-1, M0) were treated with 
breast-conserving therapy (BCT) and adjuvant radiotherapy 
with MSBT (15 Gy in 2.5 Gy fractions) followed by WBI 
(median 50.4 Gy). Toxicity was classified according to the 
Common Terminology Criteria for Adverse Events v3.0. The 
median follow-up was 21 months. 
 
Results: So far no ipsilateral breast-tumor recurrences were 
observed, 102 patients (95%) were alive at last follow-up. 
Two patients (2%) developed distant metastasis. Five patients 
(5%) died during follow-up, only one as a result of breast 
cancer. The 2-year disease-free survival was 95 ± 3%. The 
incidence of asymptomatic and symptomatic seroma in 90 
days after MSBT was 28% and 10%, respectively. Infectious 
mastitis was observed in 3 patients (3%), who were treated 
successfully with antibiotics. Only 3 patients (3%) developed 
a radiodermatitis > grade 2 after WBI. 
 
Conclusion: The boost technique used in this study seems to 
provide excellent local control with acceptable toxicity, 
similar to the results observed with other forms of interstitial 
accelerated partial-breast irradiation as a boost. Long-term 
follow-up is necessary to refine the patient selection criteria 
and to assess efficacy and late toxicities. 
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Purpose or Objective: Evaluate the necessity of a complete 
CT scan before each treatment in the APBI and the use of 
additional immobilization devices 
 
Material and Methods: A retrospective study was performed 
on 25 patients treated in the 2013-2015 period with APBI 
brachytherapy. The CT scans of each patient taken before 
each treatment were imported in to the planning system. 
Each CT scan was registered with the initial one. Dosimetric 
evaluations respective to the initial CT scan image series 
were performed. The deviation of dose received by the skin 
and ribs in each treatment were calculated and minimum, 
maximum and average dose received by skin and ribs were 
recorded and compared to the initial plan’s results. 
 
Results: Small deviations in displacements were observed 
from the SAVI applicator to the ribs and the skin surface. 
Dosimetric evaluations revealed, very small changes in the 
inter-fractionation position make significant differences in 
the maximum dose to these critical organs. As a result, the 
maximum dose varied between 10% and 32% in ribs and skin 
surface. 
 
Conclusion: The CT scan before each treatment is necessary 
to minimize the uncertainty in setup and any intervention if 
deemed necessary. This study indicates, in 30% of the cases 
needed re-planning between treatments to minimize the risk 
of critical organs to be overdosed. We conclude that the 
physicist should evaluate the position of the device by 
analyzing the CT images before each treatment and consider 
re-planning is the deviations are high. Also this study reveals 
the urgent need of improving the immobilization methods 
when treating APBI with SAVI applicator. This type of 
treatment will benefit of deformable registration at each 
treatment and adaptive planning 
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Purpose or Objective: To evaluate efficacy, clinical and 
psychological impact of chronic toxicity, of exclusive BRT of 
vaginal cuff in patients (pts) affected by endometrial cancer 
after hysterectomy (EC) 
 
Material and Methods: From January 2010 to December 2014 
we studied 108 pts with EC treated with exclusive BRT. 
Treatment was performed with cylinder in vagina to sterilize 
vaginal cuff, fractionation 6 - 30 Gy, prescription to 0.5 cm 
from surface of cylinder, active length almost 3 cm. We 
evaluated efficacy, quality of life and impact on sexual 
activity after BRT filling out a test designed to investigate 
following areas: 1) social relations and personal emotions, 2) 
couple intimacy and sexuality , 3) impact of treatment on 
sexuality and doctor-patient relationship before BRT 
 
Results: 96 evaluable pts median follow-up 24 months (range 
9-60); median age 62 years (40-88); histology revealed 2 cr. 
squamous and 94 adenocarcinoma; grading G1 for 15% , G2 
for 65% and G3 for 20% of cases; all pT1b stage; lymph node 
